Circumventing China’s firewall, and utilizing AI to invent new medication


As protests towards inflexible covid management measures in China engulfed social media prior to now week, one Twitter account has emerged because the central supply of knowledge: @李老师不是你老师 (“Instructor Li Is Not Your Instructor”). 

Folks in all places in China have despatched protest footage and real-time updates to the account via personal messages, and it has posted them, with the sender’s id hidden, on their behalf.

The person behind the account, Li, is a Chinese language painter primarily based in Italy, who requested to be recognized solely by his final identify in gentle of the safety dangers. He’s been tirelessly posting footage across the clock to assist folks inside China get info, and in addition to tell the broader world.

The work has been taking its toll—he’s obtained demise threats, and police have visited his household again in China. But it surely additionally comes with a way of liberation, Li informed Zeyi Yang, our China reporter. Learn the total story.

Biotech labs are utilizing AI impressed by DALL-E to invent new medication

The information: Textual content-to-image AI fashions like OpenAI’s DALL-E 2—packages educated to generate footage of just about something you ask for—have despatched ripples via the inventive industries. Now, two biotech labs are utilizing the sort of generative AI, generally known as a diffusion mannequin, to conjure up designs for brand spanking new sorts of protein by no means seen in nature.

Why it issues: Proteins are the basic constructing blocks of dwelling programs. These protein turbines might be directed to provide designs for proteins with particular properties, comparable to form or measurement or perform. In impact, this makes it doable to provide you with new proteins to do specific jobs on demand. Researchers hope that this can ultimately result in the event of recent and more practical medication. Learn the total story.



Please enter your comment!
Please enter your name here

Share post:



More like this